Skip to content
Send us your idea
Contact us
  • Home
  • Innovation Day
    • Innovation Day Event
    • Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Team
    • Partners
Menu
  • Home
  • Innovation Day
    • Innovation Day Event
    • Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Team
    • Partners
  • Home
  • Innovation Day
    • Innovation Day Event
    • Innovation Day Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Partners
    • Team
  • Send us your idea
  • Contact
Menu
  • Home
  • Innovation Day
    • Innovation Day Event
    • Innovation Day Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Partners
    • Team
  • Send us your idea
  • Contact
Back to overview

Tispa Medical signs Joint Ownership Agreement with Isala Ziekenhuizen

Tispa Medical - Isala

Groningen-based startup Tispa Medical has signed a Joint Ownership Agreement with Isala Ziekenhuizen to remove xylene and formalin from the pathology lab within the hospitals.

Due to its harmful effects on the environment, formalin has already been banned in the Netherlands. Hospitals however form the exception: under permit, the carcinogenic substance can be used. The Tispa Tissue Processor from Tispa Medical is known for its xylene free process using CO2 technology, but can add formalin free tissue processing as well. This new method makes tissue processing safer, faster and more sustainable: a huge benefit for everyone involved in pathology.

Source: Tispa Medical

Find out more about Tispa Medical here.

Twitter
Facebook
LinkedIn
Email
WhatsApp
Back to overview

Start growing
your business with us

Send us your idea
Get in touch
  • Home
  • News
  • Participations
  • Contact
  • Investment
  • How it works
  • Financing
  • Investment areas
  • About us
  • Company
  • Partners
  • Team
Linkedin

Contact

  • Email us
  • +31 6 22 92 66 60

Address

  • Kadijk 4, 9747 AT Groningen
  • The Netherlands

RUG Ventures is a subsidiary company of

© Copyright 2021 – RUG Ventures